Progression from high insulin resistance to type 2 diabetes does not entail additional visceral adipose tissue inflammation.
about
The Interactions of Obesity, Inflammation and Insulin Resistance in Breast CancerMetabolic aspects of adult patients with nonalcoholic fatty liver diseaseObesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammationPathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future.Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet.Granulocyte colony-stimulating factor (G-CSF): A saturated fatty acid-induced myokine with insulin-desensitizing properties in humans.Can high altitude influence cytokines and sleep?Hydroxychloroquine hindering of diabetic isletopathy carries its signature on the inflammatory cytokines.Different response to hypoxia of adipose-derived multipotent cells from obese subjects with and without metabolic syndrome.Type 2 diabetes mellitus--an autoimmune disease?HMGB1 facilitates hypoxia-induced vWF upregulation through TLR2-MYD88-SP1 pathway.Abdominal subcutaneous and visceral adipocyte size, lipolysis and inflammation relate to insulin resistance in male obese humans.No Additive Effects of Polyphenol Supplementation and Exercise Training on White Adiposity Determinants of High-Fat Diet-Induced Obese Insulin-Resistant Rats.
P2860
Q26777775-448FB8D4-E8DE-4841-A856-E67002FC7BBAQ28067490-5E859649-BCBF-4442-ACFA-32E8F83FBC54Q28078567-3292BBF6-D895-4062-901A-03B852F43C86Q30597265-39354B00-718D-4E79-9061-757F8C4214A2Q34647390-F50F6829-9D74-413C-BAE3-BCCEFF348C6BQ36740527-1A4CA7AD-4A86-4DAB-A329-873BE854D6C8Q36831048-A1D6BF16-E049-491B-B352-C85F36F03B9CQ41915768-F0CBFE3B-584E-4F65-AAB6-89AB6F6EDD8BQ45402080-D95CBAC3-ABF0-4C0D-B292-6491C0A18AB2Q46799317-757AF5E2-A4FE-4E71-917F-AC75F6B4AC9EQ51601980-FD3D94E3-31F3-41B0-A34D-1FA74F8BD521Q55030703-6845F750-3199-4E94-98FA-82D177845C92Q55046205-25978F23-5C15-4C30-B7B4-D4B05DBB6003
P2860
Progression from high insulin resistance to type 2 diabetes does not entail additional visceral adipose tissue inflammation.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Progression from high insulin ...... l adipose tissue inflammation.
@ast
Progression from high insulin ...... l adipose tissue inflammation.
@en
Progression from high insulin ...... l adipose tissue inflammation.
@nl
type
label
Progression from high insulin ...... l adipose tissue inflammation.
@ast
Progression from high insulin ...... l adipose tissue inflammation.
@en
Progression from high insulin ...... l adipose tissue inflammation.
@nl
prefLabel
Progression from high insulin ...... l adipose tissue inflammation.
@ast
Progression from high insulin ...... l adipose tissue inflammation.
@en
Progression from high insulin ...... l adipose tissue inflammation.
@nl
P2093
P2860
P921
P1433
P1476
Progression from high insulin ...... al adipose tissue inflammation
@en
P2093
Francisco Jose Tinahones
Lourdes Garrido-Sanchez
Maria Dolores Mayas
Maria Rosa Bernal-Lopez
Nuria Barbarroja
Rajaa El Bekay
P2860
P304
P356
10.1371/JOURNAL.PONE.0048155
P407
P577
2012-10-24T00:00:00Z